Skip to main content
Erschienen in:

19.03.2021 | Original Article

Spaced Intranasal Corticosteroid Therapy: A Better Treatment Option in Allergic Rhinitis?

verfasst von: Ike Thomas, Tina Thomas, Geethu Mathew, Mahika Anil Kumar, Kalyan Varghese George

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Sonderheft 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Intranasal corticosteroids are first-line therapy in the treatment of allergic rhinitis (AR) and are conventionally prescribed once daily as continuous therapy. The decreased consumption of drugs is proposed to have decreased side effects. The present study aimed at comparing the effect of INCS as a spaced therapy with the conventional continuous therapy. Case records of patients with Allergic Rhinitis, who were started on INCS were studied and improvement in symptom score was compared between continuous and spaced therapy groups. In total 182 patients with AR were studied, with 91 patients in each group. Among the total group, 57% were males, 54% were < 40 years of age, 54% had > 10 years of allergy history and 94% had no family history. There was significant improvement in mean Visual Analogue Score (VAS) for all patients in both groups (p = 0.001). However, the comparison of differences in VAS before and after therapy did not show significant difference for the two groups (p = 0.791). Our study suggests that the efficacy of INCS in controlling AR symptoms is observed to be similar with spaced therapy, as in continuous therapy. Spaced therapy may therefore be recommended for better patient compliance, lesser cost and avoidance of the side effects resulting in overall improvement of quality of life for allergic patients.
Literatur
2.
Zurück zum Zitat Wise SK et al (2018) International consensus statement on allergy and rhinology: allergic rhinitis. Int Forum Allergy Rhinol 8:108–352PubMedPubMedCentral Wise SK et al (2018) International consensus statement on allergy and rhinology: allergic rhinitis. Int Forum Allergy Rhinol 8:108–352PubMedPubMedCentral
3.
Zurück zum Zitat Juniper EF, Guyatt GH, O’Byrne PM, Viveiros M (1990) Aqueous beclomethasone dipropionate nasal spray: regular versus “as required” use in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 86:380–386CrossRefPubMed Juniper EF, Guyatt GH, O’Byrne PM, Viveiros M (1990) Aqueous beclomethasone dipropionate nasal spray: regular versus “as required” use in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 86:380–386CrossRefPubMed
4.
Zurück zum Zitat Juniper EF, Guyatt GH, Archer B, Ferrie PJ (1993) Aqueous beclomethasone dipropionate in the treatment of ragweed pollen–induced rhinitis: further exploration of “as needed” use. J Allergy Clin Immunol 92:66–72CrossRefPubMed Juniper EF, Guyatt GH, Archer B, Ferrie PJ (1993) Aqueous beclomethasone dipropionate in the treatment of ragweed pollen–induced rhinitis: further exploration of “as needed” use. J Allergy Clin Immunol 92:66–72CrossRefPubMed
5.
Zurück zum Zitat Jen A, Baroody F, de Tineo M, Haney L, Blair C, Naclerio R (2000) As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 105:732–738CrossRefPubMed Jen A, Baroody F, de Tineo M, Haney L, Blair C, Naclerio R (2000) As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 105:732–738CrossRefPubMed
6.
Zurück zum Zitat Klimek L, Bergmann KC, Biedermann T, Bousquet J, Hellings P, Jung K, Merk H, Olze H, Schlenter W, Stock P, Ring J, Wagenmann M, Wehrmann W, Mösges R, Pfaar O (2017) Visual analogue scales (VAS): measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: position paper of the German Society of Allergology (AeDA) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in collaboration with the working group on Clinical Immunology, allergology and environmental medicine of the german society of otorhinolaryngology, head and neck surgery. Allergo J Int 26(1):16–24. https://doi.org/10.1007/s40629-016-0006-7CrossRefPubMedPubMedCentral Klimek L, Bergmann KC, Biedermann T, Bousquet J, Hellings P, Jung K, Merk H, Olze H, Schlenter W, Stock P, Ring J, Wagenmann M, Wehrmann W, Mösges R, Pfaar O (2017) Visual analogue scales (VAS): measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: position paper of the German Society of Allergology (AeDA) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in collaboration with the working group on Clinical Immunology, allergology and environmental medicine of the german society of otorhinolaryngology, head and neck surgery. Allergo J Int 26(1):16–24. https://​doi.​org/​10.​1007/​s40629-016-0006-7CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Sybilski AJ (2018) Visual analogue scale. A simple tool for daily treatment monitoring in allergic rhinitis. Pediatria I Medycyna Rodzinna-Paediatrics Family Med 14(3):277–81CrossRef Sybilski AJ (2018) Visual analogue scale. A simple tool for daily treatment monitoring in allergic rhinitis. Pediatria I Medycyna Rodzinna-Paediatrics Family Med 14(3):277–81CrossRef
9.
Zurück zum Zitat Naclerio RM, Solomon W (1997) Rhinitis and inhalant allergens. JAMA 1997(278):1842–1848CrossRef Naclerio RM, Solomon W (1997) Rhinitis and inhalant allergens. JAMA 1997(278):1842–1848CrossRef
11.
Zurück zum Zitat Anderson M, Anderson P, Pipkorn U (1988) Topical glucocorticosteroids and allergen induced increase in nasal reactivity: relationship between treatment time and inhibitory effect. J Allergy Clin Immunol 82:1019–1026CrossRef Anderson M, Anderson P, Pipkorn U (1988) Topical glucocorticosteroids and allergen induced increase in nasal reactivity: relationship between treatment time and inhibitory effect. J Allergy Clin Immunol 82:1019–1026CrossRef
13.
Zurück zum Zitat Kumar R, Kumar D, Parakh A (2012) Fluticasone furoate: a new intranasal corticosteroid. J Postgrad Med 58:79–83CrossRefPubMed Kumar R, Kumar D, Parakh A (2012) Fluticasone furoate: a new intranasal corticosteroid. J Postgrad Med 58:79–83CrossRefPubMed
Metadaten
Titel
Spaced Intranasal Corticosteroid Therapy: A Better Treatment Option in Allergic Rhinitis?
verfasst von
Ike Thomas
Tina Thomas
Geethu Mathew
Mahika Anil Kumar
Kalyan Varghese George
Publikationsdatum
19.03.2021
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe Sonderheft 2/2022
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-021-02514-y

Neu im Fachgebiet HNO

Riesenzellarteriitis: bilaterale Biopsie der Temporalarterien von Vorteil

Die Riesenzellarteriitis (RZA) erfordert eine rasche und präzise Diagnose, da innerhalb weniger Tage ein schwerer, irreversibler Sehverlust drohen kann. In diesem Zusammenhang scheint die bilaterale Biopsie der Temporalarterien (TAB) der unilateralen überlegen zu sein.

Lagerungsschwindel hält trotz Manöver an: Was steckt dahinter?

Ob sich ein benigner paroxysmaler Lagerungsschwindel erfolgreich behandeln lässt, könnte einem chinesischen Team zufolge auch von psychischen Faktoren abhängen.

Lärm führt zu schnellerem Hörverlust im Alter

Ergebnisse einer US-Kohortenstudie sprechen dafür, dass Menschen, die in ihrem Leben mehr Lärm ausgesetzt waren, im Alter stärker in bestimmten Frequenzbereichen an Hörvermögen einbüßen.

Kaffee und Tee können das Risiko für Kopf-Hals-Tumoren senken

Gute Nachrichten für Kaffee- und Teetrinker: Menschen, die die Heißgetränke regelmäßig zu sich nehmen, haben ein geringeres Risiko, an bestimmten Kopf-Hals-Tumoren zu erkranken.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.